![]() |
|
|
Division of Nutrition and Dietetics, College of Pharmacy and Nutrition and * Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada S7N 5C9
3To whom correspondence should be addressed. E-mail: astephen{at}hsf.ca.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: folate deficiency methionine polyamine synthesis rats gastrointestinal tract
| INTRODUCTION |
|---|
|
|
|---|
Several potential mechanisms for the damaging effects of a low folate diet have been proposed. Folate is essential in purine synthesis and thymidylate synthesis, and it has been suggested that in folate deficiency, cellular concentrations of these essential components of DNA and RNA would be altered and nucleic acid metabolism impaired (9
). As shown in Figure 1
, folate also plays an important role in the synthesis of S-adenosylmethionine (SAM), the methyl donor in a number of essential biological reactions, including DNA methylation (9
,10
). Homocysteine receives a methyl group from 5-methyltetrahydrofolate to be converted to methionine, or in the liver from betaine, derived from choline (11
). Folate deficiency has been proposed to lead to reduced synthesis of SAM (12
), and may result in DNA hypomethylation, leading to the activation of genes normally quiescent when methylation is adequate (13
).
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
Male weanling Sprague-Dawley rats (n = 20) with weights ranging from 51.5 to 66.3 g were purchased from Charles River Canada, St. Constant, Canada. They were randomly assigned to control or folate-deficient groups of 10. Rats were housed individually in wire-bottomed stainless steel cages with controlled temperature and humidity and a 12-h light:dark cycle. Throughout a 5-wk feeding period, rats had free access to food and tap water. Food consumption and weight were measured daily. The use of animals in this experimental protocol was approved before commencement by the University of Saskatchewan Protocol Review Committee for Animal Care and Supply. Both the control and the deficient diets were based on a L-amino acid purified rodent diet first described by Walzem and Clifford (17
) but without the addition of a sulfa drug. The control diet contained 2 mg folic acid/kg diet, whereas the folate-deficient diet was identical except the folate was omitted (Dyets, Bethlehem, PA). A moderate folate deficiency was sought to resemble the likely degree of deficiency that might be encountered in a free-living population. The reason for the omission of the sulfa drug from these diets was to avoid interference with polyamine synthesis by the intestinal microflora. A pilot study comparing the folate-deficient diet with and without succinylsulfathiazole indicated no differences in plasma folate concentrations. Male adult Sprague-Dawley rats (n = 6) were fed standard nonpurified rodent diet (Federated Co-op, Saskatoon, Canada). The pooled plasma from these rats was used as a quality control sample for the folate assay.
Sample collection.
After the 5-wk feeding period, rats were anesthetized with isoflurane (Abbott Laboratories, Saint-Laurent, Canada). The abdomen and chest were opened. Blood was drawn directly from the left ventricle into EDTA-containing Vacutainer tubes. After blood collection, the rats were killed by decapitation. Pieces of ileum, jejunum and colon (2 cm), 2 g of liver tissue and the right half of the brain were cut, washed in ice-cold saline, weighed and then homogenized in 0.5 mol/L perchloric acid (PCA) solution (2.5 mL for the intestinal segments, 20 mL for the liver and 10 mL for the brain). Tissue samples were stored at -20°C until analysis. For the folate assay, a portion of whole blood was diluted 10 times with a 0.1 mol/L phosphate buffer containing 1 g/100 g sodium ascorbate at pH 7.0. Before analysis, buffer-diluted whole blood was further diluted 1:50 or 1:80. The remaining blood was centrifuged at 800 x g for 10 min, and 0.1-mL aliquots of plasma were stored at -70°C until analysis. Plasma was diluted 1:4 or 1:7 before the folate assay. For the polyamine analysis, 0.5-mL aliquots of plasma were mixed with 1 mol/L PCA solution to achieve a final concentration of 0.5 mol/L and were stored at -20°C until analysis.
Analytical methods.
Plasma and RBC folate were determined using a procedure based on the microbiological method developed by Tamura (18
). Samples were added to 96-well tissue culture plates, and serial dilutions were made with ascorbate phosphate buffer (1 g/100 g sodium ascorbate, 0.1 mol/L KH2PO4, pH 6.3). Glycerol-protected Lactobacillus casei (ATCC 7469; American Type Culture Collection, Rockville, MD) was mixed with the assay medium to a concentration of 1% (150 µL glycerol-protected bacteria in 15 mL of medium) and then 150 µL was added to each well. The plate was sealed in a plastic bag, incubated at 37°C for 18 h and read on a Titertek Multiskan microplate reader (Flow Laboratories, Mississauga, Canada) at a wavelength of 492 nm. The folate concentration of the pooled rat plasma sample was determined with each assay, with a CV of 10%.
Polyamines were measured by a modified HPLC method based on the procedure of Verkoelen et al. (19
) with 1,7-heptanediamine as the internal standard, made up as a stock solution of 0.15 g in 50 mL doubly distilled water, and diluted 1:3 as a working standard before use. The working internal standard (10 µL) was added to plasma and tissue homogenates, which were then centrifuged at 10,000 x g for 10-30 min, and the supernatant of 200400 µL was adjusted to a final volume of 0.5 mL with 0.5 mol/L PCA before derivatization. Derivatives were obtained by adding 2 mL of 2 mol/L NaOH and 20 µL benzoyl chloride to each tube and mixing vigorously for 30 min at room temperature, after which 3.5 mL of chloroform was added. After centrifugation at 350 x g for 10 min and removal of the top alkaline phase, the chloroform layer was washed with doubly distilled water 3 times; a 3-mL aliquot was removed and evaporated completely at 80°C.
For analysis, the residue was reconstituted with the mobile phase methanol:H2O (58:42 v/v). Each sample or standard (100 µL) was injected onto a 3.2 x 250 mm LiChrospher RP-18 analytical column (Supelco, Oakville, Canada) on a Waters 710B HPLC system (Waters Associates, Milford, MA), with a 490 Programmable Multiwavelength detector. Samples were analyzed at a flow rate of 0.6 mL/min at room temperature, with UV detection at 229 nm. Each run was completed in 40 min. Quality control samples, containing putrescine, spermidine and spermine were prepared, 2 at low concentration, 2 at a middle concentration and 2 at a high concentration and were analyzed with each run. These quality control concentrations varied with the tissue being analyzed; e.g., for the colon, the low standard contained 4 x 10-7 mol/L putrescine, 6 x 10-6 mol/L spermidine and 3 x 10-6 mol/L spermine; for brain, the low standard contained 4 x 10-7 mol/L putrescine, 30 x 10-6 mol/L spermidine and 14 x 10-6 mol/L spermine. The protein concentration of tissue samples was used to normalize the polyamine values by expressing these as nmol polyamine/mg protein.
Protein was measured using the method of Lowry et al. (20
) with albumin as the standard. Tissue homogenates were diluted with 1 mol/L NaOH (100250 µL); aliquots of these mixtures (1530 µL) were added to SDS (1 g/100 g) to a total volume of 200 µL for analysis. Hemoglobin and hematocrit of rats were measured at Prairie Diagnostic Service, College of Veterinary Medicine, University of Saskatchewan.
Statistical methods.
Results are expressed as means ± SEM. Statistical significance of differences was evaluated using unpaired t tests. A probability of < 0.05 was used to indicate significance. All statistical analyses were preformed using Microsoft Excel 97 (Microsoft, Redmond, WA).
| RESULTS |
|---|
|
|
|---|
There were no differences in the initial body weights of rats between the control group and the deficient group (Table 1
). Total food consumption for the 5-wk feeding period for the deficient group tended to be greater (P = 0.08) than for the control. The gain:feed ratio did not differ between groups. Total weight gain of the rats and final body weight were greater in the deficient group than in the control group (P < 0.05).
|
Compared with the controls, rats fed the folate-deficient diet had a 72% reduction in plasma folate (P < 0.001) and a 42% reduction in RBC folate (P < 0.001; Table 2
). The precision around the mean estimated by calculating interday relative standard deviations based on the results of the quality control plasma sample was 10%.
|
Spermine concentration in rat plasma was below the limit of detection of the HPLC method (Table 3
). Compared with the controls, rats fed the folate-deficient diet had a 27% greater plasma putrescine concentration (P < 0.05). The folate-deficient rats had a 58% greater hepatic spermidine concentration (P < 0.001) and a 67% greater hepatic spermine concentration than controls (P < 0.01). Polyamine concentrations did not differ between the two dietary treatment groups in the brain, jejunum, ileum or colon.
|
| DISCUSSION |
|---|
|
|
|---|
Over the 5-wk feeding period, total food consumption of the deficient group tended to be greater than that of the control group and the total weight gain of the folate-deficient rats was significantly greater than that of controls despite their having almost the same initial weights. The gain:feed ratios did not differ between groups, indicating that the greater weight gain of the folate-deficient group was due to increased food consumption. Semchuk et al. (25
) did not observe significant differences in food consumption and weight gain between folate-deficient and control rats fed for 5 wk, and in a study of 25 wk, rats appeared healthy and no significant differences in weight gain between folate-deficient and control rats were observed (26
). Our finding that folate-deficient rats gained more weight than controls was unexpected. However, the pellets of the folate-deficient diet were broken into small pieces when they arrived and may have been easier to eat than the control diet. We contend that this was the reason for the significantly greater weight gain of the folate-deficient rats.
Contrary to our hypothesis, hepatic spermidine and spermine concentrations in the folate-depleted rats were significantly higher than those of the control group. Although SAM concentrations were not measured in our study, lower hepatic SAM concentrations have been observed in folate-deficient rats at both 15 and 24 wk of feeding compared with controls (16
). A decrease in cellular SAM level could have resulted in increases in ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAMDC) activity (27
). In cell cultures, it has been found that even when SAM was depleted to nearly undetectable levels, polyamine pools were only minimally affected because of increased activity of key enzymes in polyamine synthesis (28
).
In most tissues, 5-methyltetrahydrofolate donates a methyl group to combine with homocysteine to produce methionine, which then forms SAM (Fig. 1)
. However, in the rat liver and perhaps also the kidney, betaine, derived from choline, can also act as a methyl donor in methionine synthesis (11
). Moreover, a choline-deficient diet has been shown to result in decreased hepatic concentrations of betaine, methionine and SAM (29), indicating that the betaine pathway is important in methionine metabolism, and that the remethylation of homocysteine using 5-methyltetrahydrofolate alone cannot meet the total requirement.
It has been suggested that betaine can be used by the rat liver to compensate for inadequate folate and can maintain remethylation of homocysteine (29
31
). In studying treatment with methotrexate (MTX) (31
), a folate antagonist that decreases tetrahydrofolate supply by inhibiting dihydrofolate reductase, Barak et al. (32
) found that hepatic betaine concentrations were significantly lower than in controls, and concluded that betaine compensated for 5-methyltetrahydrofolate as a methylating agent during MTX treatment. The betaine pathway has also been shown to be able to compensate for impaired folate-dependent methionine synthesis caused by a prolonged ethanol diet. More recently, Kim et al. (33
) examined the effect of folate deficiency on hepatic choline, the precursor of betaine. In weanling rats fed a diet severely depleted in folate, hepatic SAM concentration was only 20% of control and was accompanied by significantly decreased choline levels. Secondary depletion of hepatic choline may have been caused by increased utilization to compensate for the reduced capacity of the folate-dependent transmethylation pathway in methionine synthesis. In moderate folate deficiency, hepatic SAM concentrations were 35% lower and choline concentrations 36% lower than controls, although the choline differences were not significant. Betaine and the choline-dependent remethylation pathway may not have been sufficient to maintain hepatic SAM concentrations for the extended feeding period used in that experiment (24 wk). In our study of only 5 wk, it is possible that the betaine-homocysteine transmethylation pathway was fully able to compensate in methionine metabolism for the inadequate folate supply, and that significantly increased hepatic spermidine and spermine concentrations in folate-depleted rats were part of an overcompensation of the betaine-homocysteine pathway.
There were no significant differences in polyamine concentrations in brain between folate-deficient rats and controls. However, limited transport of polyamines has been seen across the blood-brain barrier (34
); thus, it would not be surprising that brain polyamines were unchanged, whereas hepatic spermidine and spermine and plasma putrescine levels were elevated. Folate conservation in brain may also be different from other tissues (26
). Rats fed a folate-deficient diet for 25 wk showed significantly lower folate concentration in the liver, kidney and spleen, but no changes in the brain. Therefore, brain folate levels were unlikely to have been depleted and polyamine metabolism in brain was unlikely to have been affected in our study.
Polyamine concentrations in intestinal tissues were similar to those in other studies (34
36
), and no significant differences in polyamine concentrations were seen in jejunum, ileum and colon between folate-deficient and control rats. Colonic SAM levels were unchanged in rats fed moderately folate-deficient diets for 15 or 24 wk, in spite of lower colonic folate concentrations (16
), suggesting that more severe folate deficiency must be present to deplete colonic SAM. Compensation by the betaine-homocysteine transmethylation pathway may have maintained colonic mucosal SAM concentrations during folate deficiency, although it remains uncertain whether the betaine pathway is functional in the colon. Alternatively, bacteria resident in the large intestine may synthesize folate (37
), and SAM levels may have been maintained in the colon through the supply of folate from this source.
Contrary to our hypothesis, rats fed the folate-deficient diet had 30% greater plasma putrescine concentrations compared with controls, with no significant differences in plasma spermidine. The origins of plasma polyamines are not certain (38
). Food, bacterial synthesis in the gastrointestinal tract and release from cells may all contribute to plasma polyamine concentrations (38
,39
). Peripheral blood cells transport most of the circulating polyamines; erythrocytes transport the majority of spermidine and spermine, and platelets transport most of the putrescine (39
). Polyamine uptake into blood cells depends on plasma polyamine concentrations (40
).
Elevated total plasma putrescine levels have been found in mice bearing Lewis lung carcinoma (41
), and rats grafted with tumors have enhanced intestinal absorption of putrescine compared with controls (42
). In these animals, polyamine concentrations and ODC activity in intestinal mucosa were the same in tumor-bearing rats and controls, yet tumors were found to have the ability to retain putrescine from the diet (42
). The growth rate of Lewis lung carcinoma in mice has been found to be significantly reduced by inhibitors of ODC and polyamine oxidase as well as a polyamine-deficient diet (15
). In the present study, there may have been increased putrescine release into the circulation of the folate-depleted rats, resulting in significantly higher levels of plasma putrescine compared with controls. The origin of this increased putrescine is uncertain, although it is possible that more plasma putrescine was released from the liver or other tissues as a result of increased ODC activity during folate deficiency. Putrescine is the direct product of the ODC reaction, and ODC activity is thought to be critically involved in malignant transformation (43
). Tumor-bearing mice have higher plasma putrescine levels and tumor cells have the ability to capture dietary putrescine at the expense of other tissues, such as liver and intestine (41
,42
). In vitro, oncogene transcription in hepatoma cells is accompanied by a rapid increase in putrescine concentration (44
). In human breast cancer, ODC activity in tumor tissue is a negative independent prognostic factor (45
), and ODC activity in colon cancer tissue has been found to be higher than in the normal mucosa from the same patient (46
). There has also been impressive evidence linking a diminished folate status with an increased risk of colorectal cancer in humans (5
,7
). Therefore, the increased plasma putrescine level found in our study could be a favorable condition for the development of malignancy in folate-deficient rats. Our hypothesis was based on the premise that reduced polyamine concentrations would result from folate deficiency and that this might explain the impaired embryological development leading to neural tube defects. The results, on the contrary, suggest increased polyamine synthesis in folate deficiency, and may contribute instead to increased cellular growth in carcinogenesis. The results suggest little involvement of polyamines in the effects of folate deficiency in the etiology of NTD.
Our study had several limitations. The activities of key enzymes, such as ODC and SAMDC, and SAM concentrations in various tissues were not determined. Nor did we determine the concentrations of spermidine and spermine in RBC, which would have been a better indicator of circulating polyamines than the plasma concentration of spermidine. Finally, the duration of our study might have been insufficient to show the effects of folate deficiency in some tissues. These results should therefore be regarded as preliminary, and future investigations could be done to further characterize polyamine metabolism during folate deficiency. Levels of SAM in various tissues, activity of key enzymes in polyamine synthesis and the betaine methylation pathway, and the uptake of circulating polyamines by liver cells could be examined to explain the increased hepatic spermidine and spermine. Meanwhile, the uptake of polyamines from the gastrointestinal tract of folate-deficient rats could be examined to explain the origin of elevated plasma putrescine in folate deficiency. Finally, it would be worthwhile to investigate polyamine metabolism in folate-depleted rats with chemically induced carcinogenesis, as well as folate depletion over the long term.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supported by the Natural Sciences and Engineering Research Council of Canada. ![]()
4 Present address: Dr. Alison M. Stephen, Director, Research Heart and Stroke Foundation of Canada, Ottawa, ON K1P 5V9, Canada. ![]()
5 Abbreviations used: MTX, methotrexate; NTD, neural tube defects; ODC, ornithine decarboxylase; PCA, perchloric acid; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; SAMDC, S-adenosylmethionine decarboxylase. ![]()
Manuscript received 8 January 2002. Initial review completed 18 January 2002. Revision accepted 27 March 2002.
| LITERATURE CITED |
|---|
|
|
|---|
1. Wald, N. J., Law, M. R., Morris, J. K. & Wald, D. S. (2001) Quantifying the effect of folic acid. Lancet 358:2069-2073.[Medline]
2. Moyers, S. & Bailey, L. B. (2001) Fetal malformations and folate metabolism: review of recent evidence. Nutr. Rev. 59:215-224.[Medline]
3. Thompson, S., Torres, M., Stevenson, R., Dean, J. & Best, R. (2000) Periconceptional vitamin use, dietary folate and occurrent neural tube defected pregnancies in a high risk population. Ann. Epidemiol. 10:476(abs.).
4. Terry, P., Jain, M., Miller, A. B., Howe, G. R. & Rohan, T. E. (2002) Dietary intake of folic acid and colorectal cancer risk in a cohort of women. Int. J. Cancer 97:864-867.[Medline]
5. Glynn, S. A. & Albanes, D. (1994) Folate and cancer: a review of the literature. Nutr. Cancer 22:101-119.[Medline]
6. Ulvik, A., Evensen, E. T., Lien, E. A., Hoff, G., Vollset, S. E., Majak, B. M. & Ueland, P. M. (2001) Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am. J. Med. Genet. 101:246-254.[Medline]
7. Kim, Y. I. (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J. Nutr. Biochem. 10:66-88.[Medline]
8. Cravo, M. L., Mason, J. B., Dayal, Y., Hutchinson, M., Smith, D., Selhub, J. & Rosenberg, I. H. (1992) Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res. 52:5002-5006.
9. Riggs, A. D. & Jones, P. A. (1983) 5-Methylcytosine, gene regulation, and cancer. Adv. Cancer Res. 40:1-30.[Medline]
10. Finkelstein, J. D. (1990) Methionine metabolism in mammals. J. Nutr. Biochem. 1:228-237.[Medline]
11. Finkelstein, J. D., Kyle, W. E. & Harris, B. J. (1971) Methionine metabolism in mammals. Regulation of homocysteine methyltransferases in rat tissue. Arch. Biochem. Biophys. 146:84-92.[Medline]
12. Miller, J. W., Nadeau, M. R., Smith, J., Smith, D. & Selhub, J. (1994) Folate deficiency induced homocysteinemia in rats: disruption of S-adenosylmethionine coordinate regulation of homocysteine metabolism. Biochem. J. 298:415-419.
13. Choi, S. W. & Mason, J. B. (2000) Folate and carcinogenesis: an integrated scheme. J. Nutr. 130:129-132.
14. Mudd, S. H. & Poole, J. R. (1975) Labile methyl balances for normal humans on various dietary regimens. Metabolism 24:721-735.[Medline]
15. Seiler, N. (1990) Polyamine metabolism. Digestion 46(Suppl.):319-330.
16. Kim, Y. I., Christman, J. K., Fleet, J. C., Cravo, M. L., Salomon, R. N., Smith, D., Ordovas, J., Selhub, J. & Mason, J. B. (1995) Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am. J. Clin. Nutr. 61:1083-1090.
17. Walzem, R. L. & Clifford, A. J. (1988) Folate deficiency in rats fed diets containing free amino acids or intact proteins. J. Nutr. 118:1089-1096.
18. Tamura, T. (1990) Microbiological assay of folate. Picciano, M. F. Stokstad, E.L.R. Gregory, J. F. eds. Folic Acid Metabolism in Health and Disease 1990:121-137 Wiley-Liss New York, NY. .
19. Verkoelen, C. F., Romijn, J. C. & Schroeder, F. H. (1988) Quantitation of polyamines in cultured cells and tissue homogenates by reversed-phase high-performance liquid chromatography of their benzoyl derivatives. J. Chromatogr. 426:41-54.[Medline]
20. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
21. Balaghi, M. & Wagner, C. (1993) DNA methylation in folate deficiency: use of CpG methylase. Biochem. Biophys. Res. Commun. 193:1184-1190.[Medline]
22. James, S. J., Basnakian, A. G. & Miller, B. J. (1994) In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res. 54:5075-5080.
23. Blount, B. C., Mack, M. M., Wehr, C. M., MacGregor, J. T., Hiatt, R. A., Wang, G., Wickramasinghe, S. N., Everson, R. B. & Ames, B. N. (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA 94:3290-3295.
24. Choi, S. W., Kim, Y. I., Weitzel, J. N. & Mason, J. B. (1998) Folate depletion impairs DNA excision repair in the colon of the rat. Gut 43:93-99.
25. Semchuk, G. M., Allen, O. B. & OConnor, D. L. (1994) Folate bioavailability from milk-containing diets is affected by altered intestinal biosynthesis of folate in rats. J. Nutr. 124:1118-1125.
26. Varela-Moreiras, G. & Selhub, J. (1992) Long-term folate deficiency alters folate content and distribution differentially in rat tissues. J. Nutr. 122:986-991.
27. Kramer, D. L., Sufrin, J. R. & Porter, C. W. (1987) Relative effects of S-adenosylmethionine depletion on nucleic acid methylation and polyamine biosynthesis. Biochem. J. 247:259-265.[Medline]
28. Kramer, D. L., Sufrin, J. R. & Porter, C. W. (1988) Modulation of polyamine-biosynthetic activity by S-adenosylmethionine depletion. Biochem. J. 249:581-586.[Medline]
29. Finkelstein, J. D., Martin, J. J., Harris, B. J. & Kyle, W. E. (1982) Regulation of the betaine content of rat liver. Arch. Biochem. Biophys. 218:169-173.[Medline]
30. Zeisel, S. H., Zola, T., Costa, K. & Pomfret, E. A. (1989) Effect of choline deficiency on S-adenosylmethionine and methionine concentrations in rat liver. Biochem. J. 259:725-729.[Medline]
31. Barak, A. J., Kemmy, R. J. & Tuma, D. J. (1982) The effect of methotrexate on homocysteine methylating agents in rat liver. Drug-Nutr. Interact. 1:303-306.
32. Barak, A. J., Beckenhauer, H. C., Tuma, D. J. & Badakhsh, S. (1986) Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochem. Cell Biol. 65:230-233.
33. Kim, Y. I., Miller, J. W., Costa, K., Nadeau, M., Smith, D., Selhub, J., Zeisel, S. H. & Mason, J. B. (1994) Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver. J. Nutr. 124:2197-2203.
34. Shin, W. W., Fong, W. F., Pang, S. F. & Wong, P. C. (1985) Limited blood-brain barrier transport of polyamines. J. Neurochem. 44:1056-1059.[Medline]
35. Porter, C. W., Dworaczyk, D., Ganis, B. & Weiser, M. M. (1980) Polyamines and biosynthetic enzymes in the rat intestinal mucosa and the influence of methylglyoxal-bis(guanylhydrazone). Cancer Res. 40:2330-2335.
36. Dufour, C., Dandrifosse, G., Forget, P., Vermesse, F., Romain, N. & Lepoint, P. (1988) Spermine and spermidine induce intestinal maturation in the rat. Gastroenterology 95:112-116.[Medline]
37. Rong, N., Selhub, J., Goldin, B. R. & Rosenberg, I. H. (1991) Bacterially synthesized folate in rat large intestine is incorporated into host tissue folyl polyglutamates. J. Nutr. 121:1955-1959.
38. Brosnan, M. E., Ray, S., Walters, B. & Pink, D. (1997) How does the kidney handle plasma polyamines?. Contrib. Nephrol. 121:129-135.[Medline]
39. Moulinoux, J. Ph., Quemener, V. & Khan, N. A. (1991) Biological significance of circulating polyamines in oncology. Cell. Mol. Biol. 37:773-783.[Medline]
40. Moulinoux, J. Ph., Le Calve, M., Quemener, V. & Quash, G. (1984) In vitro studies on the entry of polyamines into normal red blood cells. Biochimie 66:385-393.[Medline]
41. Catros-Quemener, V., Leray, G., Moulinoux, J. P., Havouis, R., de Certaines, J. D. & Chapman, J. (1997) Tumour growth modifies intravascular polyamine transport by plasma lipoproteins in the mouse. Biochim. Biophys. Acta 1346:30-37.[Medline]
42. Brachet, P., Quemener, V., Havouis, R., Tomé, D. & Moulinoux, J. (1994) Alterations in intestinal uptake of putrescine and tissue polyamine concentration in tumor-bearing rats. Biochim. Biophys. Acta 1227:161-170.[Medline]
43. Auvinen, M., Paasinen, A., Andersson, L. C. & Holtta, E. (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature (Lond.) 360:355-358.[Medline]
44. Lafarge-Frayssinet, C., Cassingena, R., Frayssinet, C., Estrade, S., Havouis, R. & Moulinoux, J. Ph. (1993) Polyamine content and oncogene expression in hepatoma cells in culture during methionine deprivation and refeeding. Anticancer Res. 13:491-496.[Medline]
45. Manni, A., Mauger, D., Gimotty, P. & Badger, B. (1996) Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin. Cancer Res. 2:1901-1906.[Abstract]
46. Rozhin, J., Wilson, P. S., Bull, A. W. & Nigro, N. D. (1984) Ornithine decarboxylase activity in the rat and human colon. Cancer Res. 44:3226-3230.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||